[Matrix metalloproteinases and their inhibitors in ovarian cancer progression--diagnostic and therapeutic implications].

@article{Stettner2009MatrixMA,
  title={[Matrix metalloproteinases and their inhibitors in ovarian cancer progression--diagnostic and therapeutic implications].},
  author={Rafał Stettner and Michał Bogusiewicz and Tomasz Rechberger},
  journal={Ginekologia polska},
  year={2009},
  volume={80 1},
  pages={
          47-53
        }
}
Matrix metalloproteinases are proteolytic enzymes which degrade extracellular matrix proteins. Along with their specific inhibitors--issue inhibitors of metalloproteinases--they play an important role in the spreading of malignant tumours. The research conducted in recent years has shown that metalloproteinases and their inhibitors contribute substantially to the ovarian cancer progression, participating both in in situ tumours growth, and the spreading of neoplasm via peritoneal fluid. The… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 71 REFERENCES

The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.

  • Journal of experimental & clinical cancer research : CR
  • 2002
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Local proteolytic activity in tumor cell invasion and metastasis.

  • BioEssays : news and reviews in molecular, cellular and developmental biology
  • 2005
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Structural studies of matrix metalloproteinases

  • Journal of Molecular Medicine
  • 2000
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Matrix metalloproteinase inhibitors

VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer

A Ascar, A Onan, U Coskun, al.. et
  • Med Oncol
  • 2008
VIEW 2 EXCERPTS

Similar Papers

Loading similar papers…